• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型氨基酸取代四环咪唑并[4,5-b]吡啶衍生物的设计、合成、抗增殖活性及 DNA/RNA 结合研究。

Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study.

机构信息

Pliva d.o.o., odjel TAPI I&R, Unapređenje tehnoloških procesa i Podrška proizvodnji, Croatia.

Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Marulićev trg 19, HR-10000, Zagreb, Croatia.

出版信息

Eur J Med Chem. 2021 May 5;217:113342. doi: 10.1016/j.ejmech.2021.113342. Epub 2021 Mar 3.

DOI:10.1016/j.ejmech.2021.113342
PMID:33751978
Abstract

A novel series of tetracyclic imidazo[4,5-b]pyridine derivatives was designed and synthesized as potential antiproliferative agents. Their antiproliferative activity against human cancer cells was influenced by the introduction of chosen amino side chains on the different positions on the tetracyclic skeleton and particularly, by the position of N atom in the pyridine nuclei. Thus, the majority of compounds showed improved activity in comparison to standard drug etoposide. Several compounds showed pronounced cytostatic effect in the submicromolar range, especially on HCT116 and MCF-7 cancer cells. The obtained results have confirmed the significant impact of the position of N nitrogen in the pyridine ring on the enhancement of antiproliferative activity, especially for derivatives bearing amino side chains on position 2. Thus, regioisomers 6, 7 and 9 showed noticeable enhancement of activity in comparison to their counterparts 10, 11 and 13 with IC values in a nanomolar range of concentration (0.3-0.9 μM). Interactions with DNA (including G-quadruplex structure) and RNA were influenced by the position of amino side chains on the tetracyclic core of imidazo[4,5-b]pyridine derivatives and the ligand charge. Moderate to high binding affinities (logK = 5-7) obtained for selected imidazo[4,5-b]pyridine derivatives suggest that DNA/RNA are potential cell targets.

摘要

设计并合成了一系列新型四环咪唑并[4,5-b]吡啶衍生物,作为有潜力的抗增殖剂。它们对人癌细胞的抗增殖活性受到四环骨架上不同位置引入的所选氨基侧链的影响,特别是吡啶核中氮原子的位置。因此,大多数化合物与标准药物依托泊苷相比表现出更好的活性。一些化合物在亚微摩尔范围内表现出明显的细胞生长抑制作用,特别是对 HCT116 和 MCF-7 癌细胞。获得的结果证实了吡啶环中 N 氮位置对增强抗增殖活性的重要影响,特别是对于在 2 位带有氨基侧链的衍生物。因此,与在相同位置带有氨基侧链的 10、11 和 13 相比,6、7 和 9 这几个区域异构体的活性有显著提高,IC 值在纳摩尔浓度范围内(0.3-0.9 μM)。与 DNA(包括 G-四链体结构)和 RNA 的相互作用受到四环咪唑并[4,5-b]吡啶衍生物中环上氨基侧链的位置和配体电荷的影响。所选咪唑并[4,5-b]吡啶衍生物的结合亲和力适中至较高(logK=5-7),表明 DNA/RNA 是潜在的细胞靶标。

相似文献

1
Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study.新型氨基酸取代四环咪唑并[4,5-b]吡啶衍生物的设计、合成、抗增殖活性及 DNA/RNA 结合研究。
Eur J Med Chem. 2021 May 5;217:113342. doi: 10.1016/j.ejmech.2021.113342. Epub 2021 Mar 3.
2
Design, Synthesis, Antitumor Activity and NMR-Based Metabolomics of Novel Amino Substituted Tetracyclic Imidazo[4,5-b]Pyridine Derivatives.新型氨基取代四环咪唑并[4,5-b]吡啶衍生物的设计、合成、抗肿瘤活性及基于 NMR 的代谢组学研究。
ChemMedChem. 2024 Sep 2;19(17):e202300633. doi: 10.1002/cmdc.202300633. Epub 2024 Jul 16.
3
Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.具有抗黑色素瘤细胞增殖活性的新型咪唑并[1,2-a]吡啶和咪唑并[1,2-a]吡嗪衍生物的设计与合成。
Eur J Med Chem. 2016 Jan 27;108:623-643. doi: 10.1016/j.ejmech.2015.12.001. Epub 2015 Dec 12.
4
Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents.咪唑并[4,5-b]吡啶衍生的嘌呤生物电子等排体的设计、合成及构效关系(SAR)研究及其作为细胞毒性剂的潜力。
Eur J Med Chem. 2015 Jan 7;89:21-31. doi: 10.1016/j.ejmech.2014.10.037. Epub 2014 Oct 14.
5
Design and synthesis of novel imidazo[4,5-b]pyridine based compounds as potent anticancer agents with CDK9 inhibitory activity.设计并合成新型咪唑并[4,5-b]吡啶类化合物作为具有 CDK9 抑制活性的强效抗癌剂。
Bioorg Chem. 2018 Oct;80:565-576. doi: 10.1016/j.bioorg.2018.07.006. Epub 2018 Jul 6.
6
Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.设计、合成及评价新型 2-(1H-咪唑-2-基)吡啶索拉非尼衍生物作为潜在的 BRAF 抑制剂和抗肿瘤药物。
Eur J Med Chem. 2015 Jan 27;90:170-83. doi: 10.1016/j.ejmech.2014.11.008. Epub 2014 Nov 6.
7
Design, synthesis, and molecular docking study of 3H-imidazole[4,5-c]pyridine derivatives as CDK2 inhibitors.设计、合成及 3H-咪唑并[4,5-c]吡啶衍生物作为 CDK2 抑制剂的分子对接研究。
Arch Pharm (Weinheim). 2018 Jun;351(6):e1700381. doi: 10.1002/ardp.201700381. Epub 2018 Apr 30.
8
Design, synthesis and biological evaluation of novel 3H-imidazole [4,5-b] pyridine derivatives as selective mTOR inhibitors.新型3H-咪唑并[4,5-b]吡啶衍生物作为选择性mTOR抑制剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2017 Aug 1;27(15):3395-3398. doi: 10.1016/j.bmcl.2017.06.010. Epub 2017 Jun 3.
9
Synthesis and antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.咪唑并[2,1 - b][1,3,4]噻二唑衍生物的合成与抗增殖活性
Bioorg Med Chem Lett. 2014 Oct 1;24(19):4682-4688. doi: 10.1016/j.bmcl.2014.08.032. Epub 2014 Aug 26.
10
Design, synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6 (1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyridine analogues as antiproliferative agents.设计、合成及 2-(3,4-二甲氧基苯基)-6-(1,2,3,6-四氢吡啶-4-基)咪唑并[1,2-a]吡啶类似物的抗肿瘤活性评价。
Bioorg Med Chem Lett. 2019 Sep 15;29(18):2551-2558. doi: 10.1016/j.bmcl.2019.08.013. Epub 2019 Aug 7.

引用本文的文献

1
Proton and Metal Dication Affinities of Tetracyclic Imidazo[4,5-]Pyridine-Based Molecules: Insights from Mass Spectrometry and DFT Analysis.基于四环咪唑并[4,5 - ]吡啶的分子对质子和金属二价阳离子的亲和力:来自质谱和密度泛函理论分析的见解
Molecules. 2025 Jun 21;30(13):2684. doi: 10.3390/molecules30132684.
2
Imidazopyridine Family: Versatile and Promising Heterocyclic Skeletons for Different Applications.咪唑并吡啶家族:适用于不同应用的多功能且有前景的杂环骨架。
Molecules. 2024 Jun 5;29(11):2668. doi: 10.3390/molecules29112668.
3
Receptor Targeting Using Copolymer-Modified Gold Nanoparticles for pCMV-Luc Gene Delivery to Liver Cancer Cells In Vitro.
使用共聚体修饰的金纳米颗粒进行受体靶向,将 pCMV-Luc 基因递送至肝癌细胞的体外研究。
Int J Mol Sci. 2024 May 4;25(9):5016. doi: 10.3390/ijms25095016.
4
Synthesis and Biological Evaluation of Novel Amino and Amido Substituted Pentacyclic Benzimidazole Derivatives as Antiproliferative Agents.新型含氨基和酰胺基取代的五环苯并咪唑衍生物的合成及生物评价作为抗增殖剂。
Int J Mol Sci. 2024 Feb 14;25(4):2288. doi: 10.3390/ijms25042288.
5
Design, Synthesis, and Anti-Breast Cancer Potential of Imidazole-Pyridine Hybrid Molecules and Ehrlich Ascites Carcinoma Growth Inhibitory Activity Assessment .咪唑 - 吡啶杂化分子的设计、合成及抗乳腺癌潜力与艾氏腹水癌生长抑制活性评估
ACS Omega. 2023 Oct 19;8(43):40287-40298. doi: 10.1021/acsomega.3c04384. eCollection 2023 Oct 31.
6
Synthesis and Antiproliferative Activity of 2,6-Disubstituted Imidazo[4,5-]pyridines Prepared by Suzuki Cross Coupling.通过 Suzuki 交叉偶联合成 2,6-二取代咪唑并[4,5-b]吡啶及其抗增殖活性
Molecules. 2023 Oct 21;28(20):7208. doi: 10.3390/molecules28207208.
7
Design, Synthesis, Spectroscopic Characterisation and In Vitro Cytostatic Evaluation of Novel Bis(coumarin-1,2,3-triazolyl)benzenes and Hybrid Coumarin-1,2,3-triazolyl-aryl Derivatives.新型双(香豆素-1,2,3-三唑基)苯并化合物和香豆素-1,2,3-三唑基-芳基杂化衍生物的设计、合成、光谱特性和体外细胞抑制评估。
Molecules. 2022 Jan 19;27(3):637. doi: 10.3390/molecules27030637.
8
Inhibitory Effect of Chlorogenic Acid Analogues Comprising Pyridine and Pyrimidine on α-MSH-Stimulated Melanogenesis and Stability of Acyl Analogues in Methanol.含吡啶和嘧啶的绿原酸类似物对α-MSH刺激的黑素生成的抑制作用及酰基类似物在甲醇中的稳定性
Pharmaceuticals (Basel). 2021 Nov 17;14(11):1176. doi: 10.3390/ph14111176.
9
Biological Activity of Newly Synthesized Benzimidazole and Benzothizole 2,5-Disubstituted Furane Derivatives.新型苯并咪唑和苯并噻唑 2,5-二取代呋喃衍生物的生物活性。
Molecules. 2021 Aug 14;26(16):4935. doi: 10.3390/molecules26164935.
10
Pyridine Scaffolds, Phenols and Derivatives of Azo Moiety: Current Therapeutic Perspectives.吡啶骨架、酚类和偶氮部分的衍生物:当前的治疗视角。
Molecules. 2021 Aug 11;26(16):4872. doi: 10.3390/molecules26164872.